Propanc Biopharma (PPCB) Non-Current Debt (2013 - 2025)
Propanc Biopharma's Non-Current Debt was $65,280 in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 55.0% from $145,091 a year earlier and unchanged from the prior quarter.
Propanc Biopharma (PPCB) Non-Current Debt (2013 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Non-Current Debt at Propanc Biopharma came in at $105,627, up 80.1% from FY2024.
- Non-Current Debt shows a three-year compound annual growth rate of 50.9% (FY2022 to FY2025).
- In earlier fiscal years, Non-Current Debt was $58,642 in FY2024 (-10.2%), $65,280 in FY2023 (+112.3%) and $30,746 in FY2022.
- Quarterly Non-Current Debt has moved between $28,581 (fiscal Q1 2024) and $145,091 (fiscal Q2 2025) over five years.
- Compared with a year earlier, Non-Current Debt was higher in four of the last eight quarters, with growth averaging 96.5%.
- The best year-over-year quarter for Non-Current Debt over five years was fiscal Q1 2025 (growth of 407.6%); the worst was fiscal Q1 2026 (a decline of 55.0%).
- Per Business Quant data, PPCB's Non-Current Debt in the three fiscal quarters before Q2 2026 was $65,280 (Q1 2026), $105,627 (Q4 2025) and $93,913 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.41 Bn | 1,108.99 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 618.57 Bn | 537.10 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 509.95 Bn | 483.06 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 366.63 Bn | 321.01 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 298.47 Bn | 262.46 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 263.21 Bn | 236.89 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 236.71 Bn | 192.11 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 193.05 Bn | 167.25 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Propanc Biopharma | 357,002.35 | -1.65 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 65,280.00 |
| Sep 30, 2025 | 65,280.00 |
| Jun 30, 2025 | 105,627.00 |
| Mar 31, 2025 | 93,913.00 |
| Dec 31, 2024 | 145,091.00 |
| Sep 30, 2024 | 145,091.00 |
| Jun 30, 2024 | 58,642.00 |
| Mar 31, 2024 | 48,218.00 |
| Dec 31, 2023 | 35,214.00 |
| Sep 30, 2023 | 28,581.00 |
| Jun 30, 2023 | 65,280.00 |
| Mar 31, 2023 | 49,558.00 |
| Dec 31, 2022 | 50,357.00 |
| Jun 30, 2022 | 30,746.00 |
| Jun 30, 2018 | 54,753.00 |
| Mar 31, 2018 | 56,906.00 |
| Jun 30, 2017 | 56,802.00 |
| Dec 31, 2016 | 2,159.00 |
| Sep 30, 2016 | 2,300.00 |
| Jun 30, 2016 | 2,220.00 |
Propanc Biopharma Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=PPCB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();